ask="16.38"
ask_size="100"
average_daily_volume="43"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="+0.00"
change_from_200_day_moving_average="-8.53"
change_from_50_day_moving_average="-2.82"
change_from_52_week_high="-9.03"
change_From_52_week_low="0.00"
change_in_percent="+0.00%"
close="3.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="N/A"
high_52_weeks="12.74"
last_trade_date="3/9/2017"
last_trade_price="3.71"
last_trade_size="N/A"
last_trade_time="12:10pm"
low="N/A"
low_52_weeks="3.71"
market_capitalization="4.27B"
moving_average_200_day="12.24"
moving_average_50_day="6.53"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="N/A"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-69.69%"
percent_change_from_50_day_moving_average="-43.19%"
percent_change_from_52_week_high="-70.88%"
percent_change_from_52_week_low="+0.00%"
previous_close="3.71"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="1150000000"
short_ratio="0.00"
stock_exchange="NCM"
symbol="TROVU"
volume="0"
weeks_range_52="3.71 - 12.74"
